Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.

Sankaran S, Gamble G, Bolland M, Reid IR, Grey A.

J Clin Endocrinol Metab. 2010 Apr;95(4):1653-62. doi: 10.1210/jc.2009-2384. Epub 2010 Feb 3. Review.

PMID:
20130069
[PubMed - indexed for MEDLINE]
2.

Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism.

Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K.

J Clin Endocrinol Metab. 2000 May;85(5):1901-7.

PMID:
10843172
[PubMed - indexed for MEDLINE]
3.

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.

Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S.

J Bone Miner Res. 2001 Jan;16(1):113-9.

PMID:
11149474
[PubMed - indexed for MEDLINE]
4.

Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism.

Hagström E, Lundgren E, Mallmin H, Rastad J, Hellman P.

J Intern Med. 2006 Feb;259(2):191-8.

PMID:
16420548
[PubMed - indexed for MEDLINE]
5.

The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ.

J Clin Endocrinol Metab. 2008 Sep;93(9):3462-70. doi: 10.1210/jc.2007-1215. Epub 2008 Jun 10.

PMID:
18544625
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population.

Nomura R, Sugimoto T, Tsukamoto T, Yamauchi M, Sowa H, Chen Q, Yamaguchi T, Kobayashi A, Chihara K.

Clin Endocrinol (Oxf). 2004 Mar;60(3):335-42.

PMID:
15008999
[PubMed - indexed for MEDLINE]
7.

Pre- and postoperative bone metabolism of primary hyperparathyroidism.

Suzuki S, Fukushima T, Ami H, Asahi S, Onogi H, Nakamura I, Tsuchiya A, Takenoshita S.

Biomed Pharmacother. 2000 Jun;54 Suppl 1:90s-96s.

PMID:
10915001
[PubMed - indexed for MEDLINE]
8.

Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.

Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C.

J Clin Endocrinol Metab. 2007 Aug;92(8):3114-21. Epub 2007 May 29.

PMID:
17535997
[PubMed - indexed for MEDLINE]
9.

Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment.

Gonnelli S, Montagnani A, Cepollaro C, Monaco R, Gennari L, Rossi B, Pacini S, Gennari C.

Osteoporos Int. 2000;11(3):255-60.

PMID:
10824242
[PubMed - indexed for MEDLINE]
10.

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

Khan AA, Bilezikian JP, Kung AW, Ahmed MM, Dubois SJ, Ho AY, Schussheim D, Rubin MR, Shaikh AM, Silverberg SJ, Standish TI, Syed Z, Syed ZA.

J Clin Endocrinol Metab. 2004 Jul;89(7):3319-25.

PMID:
15240609
[PubMed - indexed for MEDLINE]
11.
12.

Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study.

Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J.

Surgery. 2004 Dec;136(6):1281-8.

PMID:
15657588
[PubMed - indexed for MEDLINE]
13.

The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.

Kaji H, Yamauchi M, Chihara K, Sugimoto T.

Eur J Endocrinol. 2005 Sep;153(3):373-8.

PMID:
16131599
[PubMed - indexed for MEDLINE]
Free Article
14.

Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study.

Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L.

Bone. 1999 Nov;25(5):597-602.

PMID:
10574581
[PubMed - indexed for MEDLINE]
15.

[Alendronate increases bone mineral density in patients with symptomatic primary hyperparathyroidism].

Misiorowski W.

Endokrynol Pol. 2005 Nov-Dec;56(6):871-5. Polish.

PMID:
16821204
[PubMed - indexed for MEDLINE]
16.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

PMID:
23074491
[PubMed]
Free PMC Article
17.

Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.

Valdemarsson S, Lindergård B, Tibblin S, Bergenfelz A.

J Intern Med. 1998 Feb;243(2):115-22.

PMID:
9566639
[PubMed - indexed for MEDLINE]
18.

Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.

Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R.

J Clin Endocrinol Metab. 1996 Oct;81(10):3487-91.

PMID:
8855790
[PubMed - indexed for MEDLINE]
19.

Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.

Stilgren LS, Hegedüs LM, Beck-Nielsen H, Abrahamsen B.

Calcif Tissue Int. 2003 Sep;73(3):210-6.

PMID:
14667132
[PubMed - indexed for MEDLINE]
20.

Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism.

Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S; SIPH Study Group.

J Clin Endocrinol Metab. 2009 Jul;94(7):2255-61. doi: 10.1210/jc.2008-2742. Epub 2009 Apr 7.

PMID:
19351725
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk